FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2899802502> ?p ?o ?g. }

• W2899802502 endingPage "e0206942" @default.
• W2899802502 startingPage "e0206942" @default.
• W2899802502 abstract "Background Mitogen activated-protein kinase pathway inhibitors (MAPKis) improve treatment outcome in patients with disseminated BRAFV600 mutant cutaneous malignant melanoma (CMM) but responses are of limited duration due to emerging resistance. Although extensive research in mechanisms of resistance is being performed, predictive biomarkers for durable responses are still lacking. We used miRNA qPCR to investigate if different levels of extracellular microvesicle microRNA (EV miRNA) in matched plasma samples collected from patients with metastatic IV BRAFV600 mutated CMM before, during and after therapy with MAPKis could serve as predictive biomarkers. Materials and methods EV miRNAs were extracted from plasma samples from 28 patients collected before and during therapy, measured by quantitative PCR-array and correlated to therapy outcome. Results Increased levels of EV let-7g-5p during treatment compared to before treatment (EV let-7g-5p_delta) were associated with better disease control with MAPKis (odds ratio 8568.4, 95% CI = 4.8–1.5e+07, P = 0.000036). Elevated levels of EV miR-497-5p during therapy were associated with prolonged progression free survival (PFS) (hazard ratio = 0.27, 95% CI = 0.13–0.52, P <0.000061). Conclusions EV miRNAs let-7g-5p and miR-497-5p were identified as putative novel predictive biomarkers of MAPKi treatment benefit in metastatic CMM patients highlighting the potential relevance of assessing EV miRNA during and after treatment to unravel novel mechanisms of resistance." @default.
• W2899802502 created "2018-11-16" @default.
• W2899802502 creator A5012469479 @default.
• W2899802502 creator A5024889166 @default.
• W2899802502 creator A5062707573 @default.
• W2899802502 creator A5068306677 @default.
• W2899802502 creator A5068824436 @default.
• W2899802502 creator A5079932614 @default.
• W2899802502 creator A5084535555 @default.
• W2899802502 creator A5091798251 @default.
• W2899802502 date "2018-11-06" @default.
• W2899802502 modified "2023-10-18" @default.
• W2899802502 title "Extracellular microvesicle microRNAs as predictive biomarkers for targeted therapy in metastastic cutaneous malignant melanoma" @default.
• W2899802502 cites W1493106153 @default.
• W2899802502 cites W1864088638 @default.
• W2899802502 cites W1965370740 @default.
• W2899802502 cites W1987202159 @default.
• W2899802502 cites W1988819239 @default.
• W2899802502 cites W1996534604 @default.
• W2899802502 cites W2007499410 @default.
• W2899802502 cites W2019607817 @default.
• W2899802502 cites W2042603728 @default.
• W2899802502 cites W2047929348 @default.
• W2899802502 cites W2048883725 @default.
• W2899802502 cites W2054410308 @default.
• W2899802502 cites W2055313665 @default.
• W2899802502 cites W2065723650 @default.
• W2899802502 cites W2092437923 @default.
• W2899802502 cites W2094077020 @default.
• W2899802502 cites W2097995306 @default.
• W2899802502 cites W2110065044 @default.
• W2899802502 cites W2115093090 @default.
• W2899802502 cites W2118863192 @default.
• W2899802502 cites W2121545342 @default.
• W2899802502 cites W2128035403 @default.
• W2899802502 cites W2128542677 @default.
• W2899802502 cites W2136474966 @default.
• W2899802502 cites W2144038313 @default.
• W2899802502 cites W2151922790 @default.
• W2899802502 cites W2152897456 @default.
• W2899802502 cites W2160766792 @default.
• W2899802502 cites W2162489334 @default.
• W2899802502 cites W2163188200 @default.
• W2899802502 cites W2166262263 @default.
• W2899802502 cites W2169491358 @default.
• W2899802502 cites W2292376287 @default.
• W2899802502 cites W2295135463 @default.
• W2899802502 cites W2315542084 @default.
• W2899802502 cites W2560367415 @default.
• W2899802502 cites W2725858897 @default.
• W2899802502 cites W2801335131 @default.
• W2899802502 doi "https://doi.org/10.1371/journal.pone.0206942" @default.
• W2899802502 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6219796" @default.
• W2899802502 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30399176" @default.
• W2899802502 hasPublicationYear "2018" @default.
• W2899802502 type Work @default.
• W2899802502 sameAs 2899802502 @default.
• W2899802502 citedByCount "31" @default.
• W2899802502 countsByYear W28998025022019 @default.
• W2899802502 countsByYear W28998025022020 @default.
• W2899802502 countsByYear W28998025022021 @default.
• W2899802502 countsByYear W28998025022022 @default.
• W2899802502 countsByYear W28998025022023 @default.
• W2899802502 crossrefType "journal-article" @default.
• W2899802502 hasAuthorship W2899802502A5012469479 @default.
• W2899802502 hasAuthorship W2899802502A5024889166 @default.
• W2899802502 hasAuthorship W2899802502A5062707573 @default.
• W2899802502 hasAuthorship W2899802502A5068306677 @default.
• W2899802502 hasAuthorship W2899802502A5068824436 @default.
• W2899802502 hasAuthorship W2899802502A5079932614 @default.
• W2899802502 hasAuthorship W2899802502A5084535555 @default.
• W2899802502 hasAuthorship W2899802502A5091798251 @default.
• W2899802502 hasBestOaLocation W28998025021 @default.
• W2899802502 hasConcept C104317684 @default.
• W2899802502 hasConcept C121608353 @default.
• W2899802502 hasConcept C126322002 @default.
• W2899802502 hasConcept C143998085 @default.
• W2899802502 hasConcept C145059251 @default.
• W2899802502 hasConcept C156957248 @default.
• W2899802502 hasConcept C20518536 @default.
• W2899802502 hasConcept C207103383 @default.
• W2899802502 hasConcept C2777658100 @default.
• W2899802502 hasConcept C2780521871 @default.
• W2899802502 hasConcept C2781197716 @default.
• W2899802502 hasConcept C2781230642 @default.
• W2899802502 hasConcept C2909763251 @default.
• W2899802502 hasConcept C44249647 @default.
• W2899802502 hasConcept C502942594 @default.
• W2899802502 hasConcept C55493867 @default.
• W2899802502 hasConcept C60644358 @default.
• W2899802502 hasConcept C71924100 @default.
• W2899802502 hasConcept C86803240 @default.
• W2899802502 hasConceptScore W2899802502C104317684 @default.
• W2899802502 hasConceptScore W2899802502C121608353 @default.
• W2899802502 hasConceptScore W2899802502C126322002 @default.
• W2899802502 hasConceptScore W2899802502C143998085 @default.
• W2899802502 hasConceptScore W2899802502C145059251 @default.
• W2899802502 hasConceptScore W2899802502C156957248 @default.

• next